Precigen Inc (NASDAQ:PGEN) does about 1.17M shares in volume on a normal day but saw 1131107 shares change hands in Tuesday trading. The company now has a market cap of 348.49M USD. Its current market price is $1.40, marking a decrease of -0.36% compared to the previous close of $1.40. The 52 week high reached by this stock is $1.88 whilst the lowest price level in 52 weeks is $0.81.
Precigen Inc (PGEN) has a 20-day trading average at $1.5265 and the current price is -25.53% off the 52-week high compared with 73.91% distance from its 52-week low. The 50-day simple moving average of the closing price is $1.4492 and its 200-day simple moving average is $1.3273. If we look at the stock’s price movements over the week, volatility stands at 6.02%, which increases to 7.43% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 44.40 to suggest the stock is neutral.
The consensus objective for the share price is $9.00, suggesting that the stock has a potential upside of 84.44% over the period.
Cantor Fitzgerald initiated its price target at $7.
Precigen Inc (PGEN) stock is down -2.78% over the week and -8.50% over the past month. Its price is 4.48% year-to-date and 45.82% over the past year.
The stock last released its quarterly earnings report for quarter ended 12/30/2023, with the company’s earnings per share (EPS) of -$0.13 below consensus estimates by -$0.05. PGEN’s earnings per share are forecast to grow by 12.80% this year and 20.60% over next year. Expected sales for next quarter are $1.48 million, which analysts say will come at $5.52 million for the current fiscal year and next year at $38.45 million. In addition, estimates put the company’s current quarterly revenue at an average of $1.48 million.
To reach the target analysts have set, the stock logically needs to grow 84.44 percent from here.
Outstanding shares total 248.92M with insiders holding 11.31% of the shares and institutional holders owning 64.22% of the company’s common stock. The company has a return on investment of -77.10% and return on equity of -78.37%. The beta has a value of 1.73. Price to book ratio is 2.94 and price to sales ratio is 56.03.
